BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dinaciclib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dinaciclib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

at
18 shared targets
ct
8 shared targets
rg
18 shared targets
voruciclib
7 shared targets
pf
15 shared targets
zotiraciclib
14 shared targets
zemirciclib
8 shared targets
abemaciclib
14 shared targets
bms
20 shared targets
seliciclib
10 shared targets
Loading evidence profile...

This evidence profile for Dinaciclib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.